Core Laboratories (CLB)
NYSEEnergyOil & Gas Equipment & ServicesSnapshot 2026-09-09
$12.62+1.20%
Close 2026-09-09 · 1-day change
NYSEEnergyOil & Gas Equipment & ServicesSnapshot 2026-09-09
Intact: The reason to own it still holds.
Core Laboratories leads in reservoir optimization for oil and gas. It aims for revenue near $127M and profit margins above 7% next quarter. The company pays a steady dividend and has a cheap valuation versus peers. Operational efficiency efforts could improve profits over time.
Revenue and operating income have fallen sharply recently. Profit margins are low and EPS guidance is weak. The recent earnings miss and ongoing market selloff show risks. The turnaround may stall if growth and margins do not improve soon.
The price is about 18% below our fair value near $13, reflecting cautious views. Analysts expect modest 2.5% revenue growth, which aligns with our cautious outlook. The market prices in a slow recovery but not a strong turnaround yet.
Breaks if: Dividend is cut or suspended
Breaks if: EPS falls below $0.06 next quarter
Breaks if: Operating margin falls below 7% next quarter
This is not a price target or investment advice.
A long-form read on the 1–3 year hold thesis. It updates when the weekly evidence changes.
This investment represents a durable compounder with a focus on steady revenue and operating income growth. The current thesis state is cautious, as recent performance has not matched that of its industry peers.
The market appears to have priced in a low fragility tier, suggesting that expectations are justified but not overly optimistic. The valuation indicates that CLB is relatively cheap compared to its peers, with a small expectations gap.
Management is on track with priorities like driving revenue growth and returning capital to shareholders, although international operations are mixed due to external factors. The near-term risk of missing earnings is low, but the company operates in a high-miss-rate industry.
The thesis hinges on several factors, including the potential for inflation to reaccelerate, the performance of sector bellwethers, and whether CLB maintains its guidance. A cut in guidance could lead to negative market reactions.
The most important moves since the prior daily snapshot.
Mixed, the news cuts both ways. The latest earnings beat supports revenue and income growth. However, geopolitical headwinds may hinder international and offshore growth.
as of 2026-09-09
Review the evidence to watch, what would become a concern, and what would make it less concerning.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Continue efforts to enhance operational efficiency to improve financial performance.
Breaks if: Revenue falls below $121M next quarter
Over the next 1 to 3 years, CLB's performance will depend on management execution and external economic factors. Not investment advice.